Volume 11, Number 12—December 2005
Research
Postepizootic Persistence of Venezuelan Equine Encephalitis Virus, Venezuela
Juan-Carlos Navarro*, Gladys Medina†, Clovis Vasquez‡, Lark L. Coffey§, Eryu Wang§, Alexander Suárez*‡, Hernán Biord#, Marlene Salas¶, and Scott C. Weaver§
Table 2
Serologic results from equines, bovines, and wild mammals in regions of the 2000 and 2003 VEEV outbreaks*
| Location | Dates of collection | Species or common name | No. collected | Fraction HI seropositive | Fraction of HI-positive samples positive by PRNT | PRNT titers |
|---|---|---|---|---|---|---|
| Obispos | May 2002 | Proechimys guairae | 10 | 0/10 | NT | NT |
| Zygodontomys brevicauda | 47 | 0/47 | NT | NT | ||
| Zamora | May 2003 | Akodon urichi | 2 | 0/2 | NT | NT |
| Oryzomys talamancae | 1 | 0/1 | NT | NT | ||
| Sigmodon hispidus | 13 | 0/13 | NT | NT | ||
| Zygodontomys brevicauda | 1 | 0/1 | NT | NT | ||
| Didelphis marsupialis | 2 | 0/2 | NT | NT | ||
| Proechimys guairae | 18 | 0/18 | NT | NT | ||
| Rattus rattus | 2 | 0/2 | NT | NT | ||
| Bovines | 4 | 0/4 | NT | NT | ||
| June 2003 | Proechimys guairae | 6 | 1/6 | 0/1 | <20 | |
| Sep 2003 | Didelphis marsupialis | 1 | 1/1 | 0/1 | <20 | |
| Proechimys guairae | 11 | 4/11 | 0/4 | <20 | ||
| Sigmodon hispidus | 1 | 1/1 | 0/1 | <20 | ||
| Bovines | 20 | 0/20 | NT | NT | ||
| Nov 2003 | Proechimys guairae | 10 | 0/10 | NT | NT | |
| Sigmodon hispidus | 1 | 1/1 | NT | NT | ||
| Arismendi | Oct–Nov 2003 | Bovines | 48 | 12/48 | 8/12 | 40–640 |
| Antonio Jose de Sucre/Zamora | June 2003 | Proechimys guairae | 3 | 0/3 | NT | NT |
| Didelphis marsupialis | 1 | 0/1 | NT | NT | ||
| Totals | Wild mammals | 130 | 7/130 (5%) | 0/7 | <20 | |
| Bovines | 72 | 12/72 (17%) | 8/12 | 40–640 |
*VEEV, Venezuelan equine encephalitis virus; HI, hemagglutination inhibition; PRNT, plaque reduction neutralization test; NT, not tested.
Page created: February 02, 2012
Page updated: February 02, 2012
Page reviewed: February 02, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.